Advancing Medical Communications by Combining Data, Creativity and Human Expertise: Suzanne Jacobs, Real Chemistry & Trina Stonner, Avant Healthcare

·30 min·1 clip

Suzanne says the combined teams can be "market leaders" in scientific strategy, creative, and congress work.

1. The Real Chemistry Podcast episode centers on Real Chemistry’s acquisition of Avant Healthcare and the new medical group led by Suzanne Jacobs and Trina Stonner. 2. Aaron Strout hosts the discussion as Real Chemistry’s Chief Marketing Officer, Suzanne Jacobs leads the newly formed medical group, and Trina Stonner is Avant Healthcare’s Chief Customer Officer and President. 3. The episode asks what the acquisition means for medical communications, AI adoption, and the combined company’s next phase. 4. Suzanne says she was drawn to science in school, studied life science, and wanted to work in pharmaceutical drug discovery within oncology. 5. Trina says her path was "more of a crooked path," starting with fascination with the heart, a model heart in fifth grade, and a science teacher in eighth grade. 6. Trina describes work as an ICU nurse, a clinical nurse specialist, a clinical research professional, and then a pharmaceutical sales and marketing leader before joining Avant. 7. Trina says Avant is celebrating 30 years of medical education and sees the combination with Real Chemistry as a way to keep pace with a field that changes quickly. 8. She highlights Real Chemistry’s data and analytics, global presence, and broader service range as major additions to Avant’s scientific and creative strengths. 9. Suzanne says the teams have already been delivering more end-to-end medical communications for about four and a half years and can now do that more fully. 10. She names scientific strategy, scientific visualization, generative AI, and congress activity at ASCO, GI, and GU as areas where the combined team can raise its work. 11. Suzanne says post-pandemic communications must be "smarter than ever now" because scientific information is easy to access through AI platforms. 12. She says teams need clear segmentation strategies and strong physician personas before creating content or choosing channels. 13. Trina says the company must give HCPs options, including live congress experiences and interactive digital experiences, because different people want different formats. 14. She says human-to-human connection still matters in settings like boardrooms, cafeterias, physician lounges, nurses’ lounges, and pharmacies. 15. The AI discussion includes Real Chemistry platforms such as workspace and writer, plus the goal of making teams comfortable with AI across both organizations. 16. Suzanne says the combined group brings together 450 individuals, including scientists and healthcare professionals, and that the integration has to happen "on a personal level, not on a technical level." 17. Suzanne points to precision medicine, digital pathology, telehealth, and AI algorithms that can diagnose disease before symptoms appear. 18. Trina says she follows clinical trial results and recent scientific news, including a story about gene therapy restoring a child’s hearing, because it shows what is possible. 19. The episode sounds like a conversational executive interview with frequent handoffs between Aaron, Suzanne, and Trina, plus a practical business focus. 20. Listeners interested in healthcare marketing, medical affairs, AI in communications, and congress strategy will get the most from it, while people seeking narrative storytelling or technical depth may skip it.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from The Real Chemistry Podcast